Related Articles
DPD is a molecular determinant of capecitabine efficacy in colorectal cancer
Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy
Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis
Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with solid tumors
Factors predicting the response to oral fluoropyrimidine drugs: A phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study)